Edition:
United Kingdom

People: China National Medicines Corp Ltd (600511.SS)

600511.SS on Shanghai Stock Exchange

25.50CNY
20 Aug 2019
Change (% chg)

¥-0.16 (-0.62%)
Prev Close
¥25.66
Open
¥25.62
Day's High
¥25.80
Day's Low
¥25.25
Volume
3,752,785
Avg. Vol
3,264,764
52-wk High
¥28.29
52-wk Low
¥20.71

Jin, Renli 

Mr. Jin Renli has been serving as Deputy General Manager in China National Medicines Corporation Ltd. since January 24, 2019. He is also Chairman of the Board in Sinopharm Group Guorui Pharmaceutical Co., Ltd., as well as Director in Sinopharm Holdings Beijing Co., Ltd., Jiangsu Lianhuan Pharmaceutical Co., Ltd., Yichang Humanwell Pharmaceutical Co., Ltd. and Qinghai Pharmaceutical Group Co., Ltd.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Xiuchang Jiang

445,000

Lixin Shen

464,000

Zhiyuan Lu

559,000

Renli Jin

--

Wei Shao

--

Yong Yang

440,000
As Of  31 Dec 2012